跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13 条关于
“Scedosporium/Lomentospora”
全部
13
临床试验
4
药物
0
机构
0
资讯
9
3个月前
Zepto Life Technology Receives FDA Breakthrough Device Designation for FungiFlex Mold Panel Liquid Biopsy Test
去年
Basilea Launches Phase 3 Trial for Novel Antifungal Fosmanogepix in Invasive Mold Infections
3年前
F2G's Olorofim Shows 44% Response Rate in Phase 2b Trial for Invasive Fungal Infections
4个月前
F2G's Olorofim Shows Promise in High-Risk Hematology Patients with Invasive Aspergillosis
去年
F2G's Novel Antifungal Olorofim Shows Promise Despite FDA Setback, Phase 2b Results Published in The Lancet
去年
Pfizer Acquires Amplyx Pharmaceuticals to Advance Novel Antifungal Development
去年
Basilea Secures $39 Million BARDA Funding to Advance Novel Antifungal Candidates Fosmanogepix and BAL2062
上个月
Basilea Secures $30 Million BARDA Tranche to Advance Fosmanogepix Phase III Program for Invasive Fungal Infections
2个月前
Invasive Fungal Infections Market Poised for Robust Growth by 2036 as Novel Broad-Spectrum Antifungals Advance Through Pipeline